1. Home
  2. VSTM vs FEIM Comparison

VSTM vs FEIM Comparison

Compare VSTM & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • FEIM
  • Stock Information
  • Founded
  • VSTM 2010
  • FEIM 1961
  • Country
  • VSTM United States
  • FEIM United States
  • Employees
  • VSTM N/A
  • FEIM N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • FEIM Electrical Products
  • Sector
  • VSTM Health Care
  • FEIM Industrials
  • Exchange
  • VSTM Nasdaq
  • FEIM Nasdaq
  • Market Cap
  • VSTM 132.0M
  • FEIM 119.5M
  • IPO Year
  • VSTM 2012
  • FEIM N/A
  • Fundamental
  • Price
  • VSTM $3.88
  • FEIM $12.80
  • Analyst Decision
  • VSTM Strong Buy
  • FEIM
  • Analyst Count
  • VSTM 8
  • FEIM 0
  • Target Price
  • VSTM $14.57
  • FEIM N/A
  • AVG Volume (30 Days)
  • VSTM 1.1M
  • FEIM 19.0K
  • Earning Date
  • VSTM 11-06-2024
  • FEIM 12-10-2024
  • Dividend Yield
  • VSTM N/A
  • FEIM 7.98%
  • EPS Growth
  • VSTM N/A
  • FEIM N/A
  • EPS
  • VSTM N/A
  • FEIM 0.62
  • Revenue
  • VSTM $10,000,000.00
  • FEIM $57,943,000.00
  • Revenue This Year
  • VSTM N/A
  • FEIM N/A
  • Revenue Next Year
  • VSTM $125.69
  • FEIM N/A
  • P/E Ratio
  • VSTM N/A
  • FEIM $20.24
  • Revenue Growth
  • VSTM N/A
  • FEIM 28.82
  • 52 Week Low
  • VSTM $2.10
  • FEIM $7.20
  • 52 Week High
  • VSTM $14.22
  • FEIM $14.50
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 63.77
  • FEIM 52.77
  • Support Level
  • VSTM $3.11
  • FEIM $12.17
  • Resistance Level
  • VSTM $3.76
  • FEIM $12.72
  • Average True Range (ATR)
  • VSTM 0.33
  • FEIM 0.37
  • MACD
  • VSTM 0.04
  • FEIM 0.01
  • Stochastic Oscillator
  • VSTM 94.26
  • FEIM 45.37

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: